Taysha Expands Catalent Partnership
Taysha partners with Catalent for manufacturing support
Story updates
12:26:01 PM UTC
SquawkNews
TSHA CTLT Taysha Gene Therapies and Catalent expand strategic partnership to include future commercial manufacturing support of tsha-102 Gene therapy for Rett syndrome
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.